1. Home
  2. ARDX vs OMDA Comparison

ARDX vs OMDA Comparison

Compare ARDX & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.83

Market Cap

996.8M

Sector

Health Care

ML Signal

HOLD

Logo Omada Health Inc.

OMDA

Omada Health Inc.

HOLD

Current Price

$23.90

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
OMDA
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.8M
1.2B
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
ARDX
OMDA
Price
$3.83
$23.90
Analyst Decision
Strong Buy
Buy
Analyst Count
7
11
Target Price
$15.14
$21.73
AVG Volume (30 Days)
4.8M
1.4M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.27
EPS
N/A
0.04
Revenue
$2,607,000.00
$260,210,000.00
Revenue This Year
$37.75
$24.96
Revenue Next Year
$34.24
$20.08
P/E Ratio
N/A
$606.75
Revenue Growth
N/A
53.24
52 Week Low
$3.73
$10.28
52 Week High
$8.40
$26.92

Technical Indicators

Market Signals
Indicator
ARDX
OMDA
Relative Strength Index (RSI) 27.50 61.29
Support Level N/A $23.42
Resistance Level $6.47 $24.80
Average True Range (ATR) 0.14 0.91
MACD 0.01 0.01
Stochastic Oscillator 12.33 48.89

Price Performance

Historical Comparison
ARDX
OMDA

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About OMDA Omada Health Inc.

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

Share on Social Networks: